Pharma Mar (XMAD:PHM) Price-to-Operating-Cash-Flow : (As of May. 22, 2024)

View and export this data going back to 2000. Start your Free Trial

What is Pharma Mar Price-to-Operating-Cash-Flow?

As of today (2024-05-22), Pharma Mar's share price is €36.02. Pharma Mar's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.65. Hence, Pharma Mar's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Pharma Mar's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 13 years, Pharma Mar's highest Price-to-Operating-Cash-Flow Ratio was 193.47. The lowest was 4.69. And the median was 30.12.

XMAD:PHM's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 26.84
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Pharma Mar's Cash Flow from Operations per share for the three months ended in Mar. 2024 was €0.53. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.65.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Pharma Mar was -214.90% per year.

During the past 13 years, Pharma Mar's highest 3-Year average Operating Cash Flow per Share Growth Rate was 51.20% per year. The lowest was -42.20% per year. And the median was 14.20% per year.

Pharma Mar Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Pharma Mar's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Mar Price-to-Operating-Cash-Flow Chart

Pharma Mar Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

4.66

40.15

30.30

Pharma Mar Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															78.27	-	-	-	-

Competitive Comparison of Pharma Mar's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Pharma Mar's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharma Mar's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Mar's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Pharma Mar's Price-to-Operating-Cash-Flow falls into.

Pharma Mar Price-to-Operating-Cash-Flow Calculation

Pharma Mar's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	36.02	/	-0.649
	=

Pharma Mar's Share Price of today is €36.02.
Pharma Mar's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.65.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Pharma Mar Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Pharma Mar's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma Mar (XMAD:PHM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Mar SA (XMAD:PHM) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

PHMMF:USA PHMe:UK 0RC6:UK

Address

Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770

Website

http://www.pharmamar.com

Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and market insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology, Diagnostics, Consumer chemicals, and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.